91 results
424B5
SLNO
Soleno Therapeutics Inc
6 May 24
Prospectus supplement for primary offering
4:58pm
this prospectus, including redemption provisions, rights in the event of our liquidation, dissolution or winding up, voting rights and rights to convert … that will accompany this prospectus, including redemption provisions, rights in the event of our liquidation, dissolution or winding up, voting rights
424B5
SLNO
Soleno Therapeutics Inc
2 May 24
Prospectus supplement for primary offering
4:04pm
in the event of our liquidation, dissolution or winding up, voting rights and rights to convert into common stock.
Depositary Shares
We may issue fractional … provisions, rights in the event of our liquidation, dissolution or winding up, voting rights and rights to convert into common stock.
Debt Securities
We
8-K
EX-10.1
tipg5nvajr7 qpu9x
30 Jan 24
Departure of Directors or Certain Officers
4:57pm
S-3ASR
wcfucmtjhj
2 Jan 24
Automatic shelf registration
4:06pm
8-K
EX-10.2
fci0bgnx
29 Sep 23
Entry into a Material Definitive Agreement
4:55pm
424B5
0805ev64r25ri9knu
29 Sep 23
Prospectus supplement for primary offering
4:51pm
424B5
y0310dd3zact d0zn24
27 Sep 23
Prospectus supplement for primary offering
5:26pm
8-K
EX-10.2
zcw0hlkuadyuvicgs
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm
8-K
EX-10.3
uq42r4kwycz8k
19 Dec 22
Soleno Therapeutics Announces Financing Commitment for up to $60 Million
4:49pm